Medtronic's smallest CoreValve heart device wins EU approval

09/27/2012 | (Boston)

European regulators have granted Medtronic CE mark approval to market CoreValve Evolut, a 23-millimeter transcatheter aortic valve. The implantable device, which is the smallest from the firm's CoreValve line, offers a minimally invasive treatment alternative to heart disease patients who are not fit for open-heart surgery.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Counsel I – Clinical Contracts
Gilead Sciences
Foster City, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Vice President, Idaho Regional Director
Boise, ID